. Previous studies have demonstrated normal basal and stimulated growth hormone levels in subjects with Turner syndrome, as well as normal plasma levels of somatomedin-C/insulinIike growth factor I (SM-C/IGF-I) (Almquist et Rudman et al. 1981 ).
The cultured human fibroblast offers an excel¬ lent model for the evaluation of SM binding and action, since these non-transformed cells are easily obtained, can be cultured in defined medium, and lend themselves readily to experimental manipula¬ tion. High affinity receptors for SM-C/IGF-I have been previously characterized in both fibroblast suspensions (Rechler et al. 1977 ) and monolayers (Rosenfeld & Dollar 1982) , and the mitogenic action of SM in this cell system has been defined, at least in a preliminary manner (Rechler et al. 1974; Clemmons & Van Wyk 1981 ; Conover et al. 1983 ).
In the studies to (Conover et al. 1983 ). In the experi¬ ment shown in Fig. 2, the syndrome. On the basis of these studies, it was proposed that the growth failure of Turner syn¬ drome might be secondary to peripheral unresponsiveness to SM. This hypothesis was seemingly supported by the recent report of normal radioimmunoassayable SM-C levels in 5 children with Turner syndrome (Rudman et al. 1981) . Further¬ more, while GH treatment of these subjects resul¬ ted in a 100% increase in plasma SM-C levels, the regression slope of height vs SM-C level was signifi¬ cantly lower than that observed in normal and growth hormone deficient children, further sup¬ porting the concept of peripheral hyporesponsiveness in Turner syndrome.
In previous studies in achondroplastic dwarfism, employing mononuclear cells, we observed quanti¬ tatively and qualitatively normal SM-C receptors (Rosenfeld & Hintz 1980 (Stiles et al. 1979 
